A new study by investigators from Mass General Brigham uncovers how a novel immunotherapy prevents squamous cell carcinoma, ...

Expected readouts in diabetes, cancer and depression headline a series of study results that could help the biotechnology ...

An East Lancashire man has been part of a clinical trial for a new experimental drug for the most common form of bladder ...

As the new year begins, individuals looking to improve their health might consider participating in clinical trials, ...

A clinical trial manager emphasizes the importance of a phased approach to educating patients about complex protocols and ...

In this second part of our interview with Kasey Bond, MPH, NYU Langone Health, we discuss the contributions of community ...

ArMaDa clinical trial is set to assess the safety and efficacy of unilateral subretinal administration of OCU410 in subjects with GA ...

Long-term use of SGLT2 inhibitors has been linked to various positive cardiovascular outcomes, including decreased rates of ...

Nevrargenics who are behind a drug which they believe not only stops the impact of MND but reverses the damage already done.

Luke Johnston, a 10-year-old diagnosed with Retinitis Pigmentosa, is losing his eyesight, prompting his friends and family to raise millions to fund a clinical trial for a potential cure.

Study finds uneven access to prostate cancer clinical trials. While Black men's enrollment was similar to White men, Hispanic ...

India's new drug approval process waiver raises concerns about patient safety, research, and healthcare implications, experts ...